Guido Bold

3.5k total citations
46 papers, 1.8k citations indexed

About

Guido Bold is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Guido Bold has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Organic Chemistry and 19 papers in Oncology. Recurrent topics in Guido Bold's work include HIV/AIDS drug development and treatment (12 papers), Chemical Synthesis and Analysis (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Guido Bold is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Chemical Synthesis and Analysis (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Guido Bold collaborates with scholars based in Switzerland, United States and Germany. Guido Bold's co-authors include Pascal Furet, Peter Traxler, Thomas Meyer, Paul W. Manley, Giorgio Caravatti, Elisabeth Buchdunger, Jeanette M. Wood, Rudolf O. Duthaler, Terence O’Reilly and Martin Riediker and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and PLANT PHYSIOLOGY.

In The Last Decade

Guido Bold

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Bold Switzerland 25 907 758 490 132 131 46 1.8k
Steven L. Bender United States 16 1.1k 1.2× 742 1.0× 581 1.2× 100 0.8× 55 0.4× 26 2.1k
Robert E. Babine United States 14 709 0.8× 473 0.6× 299 0.6× 108 0.8× 159 1.2× 26 1.3k
Roger Bone United States 21 934 1.0× 401 0.5× 245 0.5× 115 0.9× 124 0.9× 33 1.6k
Lawrence B. Snyder United States 23 868 1.0× 940 1.2× 497 1.0× 360 2.7× 112 0.9× 40 2.5k
Joel C. Barrish United States 29 882 1.0× 1.4k 1.8× 301 0.6× 152 1.2× 40 0.3× 104 2.3k
Christian Grütter Germany 25 1.4k 1.5× 483 0.6× 400 0.8× 51 0.4× 117 0.9× 30 2.0k
Mark L. Behnke United States 15 749 0.8× 605 0.8× 248 0.5× 208 1.6× 108 0.8× 18 1.4k
Anne M. Hassell United States 21 1.6k 1.8× 585 0.8× 1.0k 2.1× 110 0.8× 184 1.4× 32 2.9k
Susan Pav United States 12 960 1.1× 344 0.5× 251 0.5× 115 0.9× 78 0.6× 16 1.4k
Denzil Bernard United States 26 1.6k 1.7× 737 1.0× 836 1.7× 74 0.6× 120 0.9× 40 2.5k

Countries citing papers authored by Guido Bold

Since Specialization
Citations

This map shows the geographic impact of Guido Bold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Bold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Bold more than expected).

Fields of papers citing papers by Guido Bold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Bold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Bold. The network helps show where Guido Bold may publish in the future.

Co-authorship network of co-authors of Guido Bold

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Bold. A scholar is included among the top collaborators of Guido Bold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Bold. Guido Bold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jahnke, Wolfgang, Guido Bold, Andreas L. Marzinzik, et al.. (2015). Gezielte Anreicherung von Wirkstoffen am Knochen am Beispiel von allosterischen FPPS‐Inhibitoren. Angewandte Chemie. 127(48). 14783–14787. 2 indexed citations
2.
Jahnke, Wolfgang, Guido Bold, Andreas L. Marzinzik, et al.. (2015). A General Strategy for Targeting Drugs to Bone. Angewandte Chemie International Edition. 54(48). 14575–14579. 22 indexed citations
3.
Vaupel, Andrea, Guido Bold, Alain De Pover, et al.. (2014). Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction. Bioorganic & Medicinal Chemistry Letters. 24(9). 2110–2114. 30 indexed citations
4.
Gäumann, Andreas, Hannes C. A. Drexler, Sven A. Lang, et al.. (2014). The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®). International Journal of Oncology. 45(6). 2267–2277. 11 indexed citations
5.
Roesel, Johannes, Pascal Furet, Guido Bold, et al.. (2010). Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison. Genes & Cancer. 1(10). 1021–1032. 33 indexed citations
6.
Halin, Cornelia, Josef G. Meingassner, Guido Bold, et al.. (2008). Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor. American Journal Of Pathology. 173(1). 265–277. 72 indexed citations
7.
8.
Roesel, Johannes, Guido Bold, Josef Brueggen, et al.. (2005). Pharmacological profile of the FLT3-Tyrosine Kinase Inhibitor AST487. Cancer Research. 65. 1409–1409. 1 indexed citations
9.
Séquin, Urs, et al.. (2004). Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor. European Journal of Medicinal Chemistry. 39(1). 11–26. 56 indexed citations
10.
Furet, Pascal, Guido Bold, Francesco Hofmann, et al.. (2003). Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorganic & Medicinal Chemistry Letters. 13(18). 2967–2971. 53 indexed citations
11.
Manley, Paul W., Pascal Furet, Guido Bold, et al.. (2002). Anthranilic Acid Amides:  A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors. Journal of Medicinal Chemistry. 45(26). 5687–5693. 83 indexed citations
12.
Homann, Stefanie, et al.. (2001). Expression and purification of human recombinant GST-FGF receptor-1. Journal of Biotechnology. 86(1). 51–58. 3 indexed citations
13.
Traxler, Peter, Guido Bold, Elisabeth Buchdunger, et al.. (2001). Tyrosine kinase inhibitors: From rational design to clinical trials. Medicinal Research Reviews. 21(6). 499–512. 265 indexed citations
14.
Altmann, Karl‐Heinz, Guido Bold, Giorgio Caravatti, et al.. (2000). Epothilones and Their Analogs – Potential New Weapons in the Fight Against Cancer. CHIMIA International Journal for Chemistry. 54(11). 612–612. 25 indexed citations
15.
Fässler, Alexander, Guido Bold, Hans‐Georg Capraro, et al.. (1996). Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability. Journal of Medicinal Chemistry. 39(16). 3203–3216. 54 indexed citations
16.
Solladié‐Cavallo, Arlette, Didier Roche, Guido Bold, et al.. (1996). Stereoselective synthesis of (4S,5R,6S)-4-(5,6-epoxy-6-phenyl)-γ-lactone. Tetrahedron Asymmetry. 7(6). 1797–1810. 4 indexed citations
17.
Bold, Guido, Robert Cozens, Jürgen Mestan, et al.. (1996). ChemInform Abstract: Aza‐Peptide Analogues as Potent Human Immunodeficiency Virus Type‐1 Protease Inhibitors with Oral Bioavailability.. ChemInform. 27(48). 2 indexed citations
18.
Capraro, Hans‐Georg, Guido Bold, Alexander Fässler, et al.. (1996). Synthesis of Potent and Orally Active HIV‐Protease Inhibitors. Archiv der Pharmazie. 329(6). 273–278. 6 indexed citations
19.
20.
Bold, Guido, Rudolf O. Duthaler, & Martin Riediker. (1989). Enantioselective Synthesis of D‐threo‐β‐Hydroxy‐α‐amino Acids with Titanium‐Carbohydrate Complexes. Angewandte Chemie International Edition in English. 28(4). 497–498. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven L. Bender Breakdown of academic impact, for papers by Robert E. Babine Breakdown of academic impact, for papers by Roger Bone Breakdown of academic impact, for papers by Lawrence B. Snyder Breakdown of academic impact, for papers by Joel C. Barrish Breakdown of academic impact, for papers by Christian Grütter Breakdown of academic impact, for papers by Mark L. Behnke Breakdown of academic impact, for papers by Anne M. Hassell Breakdown of academic impact, for papers by Susan Pav Breakdown of academic impact, for papers by Denzil Bernard
Rankless by CCL
2026